RTTNews | Jul 27, 2020 08:20AM EDT

08:19 Monday, July 27, 2020 (RTTNews) - NGM Bio Begins Phase 2 CATALINA Study Of NGM621 In Patients With Geographic Atrophy Secondary To AMD

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved